Search for: "Kennedy v. King et al" Results 1 - 20 of 28
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jun 2015, 10:57 am
June 25, 2015 On June 18, 2015, the United States Supreme Court decided the case of King, et al. v. [read post]
30 Jun 2016, 9:01 pm by John Dean
U.S. et al. are very much a part of the 2016 presidential contest. [read post]
31 Mar 2015, 1:01 pm by sgottlieb
S. ___ (2013). [2] See Brief Of Amici Curiae Professors Gary King, et al, 2006 U.S. [read post]
17 Apr 2010, 11:03 am
Kennedy, 2008 BCSC 331, 38 E.T.R. (3d) 289; Wilson v. [read post]
2 Jan 2013, 3:17 pm by assoulineberlowe
Kennedy et al FLSD   Other   Civil Rights Americans   with Disabilities Act   Boehm et al v. [read post]
25 Jun 2013, 11:31 am by Mark Walsh
James Sensenbrenner et al., who filed an amicus brief in support of the respondent in this case. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
8 Dec 2024, 6:48 am by Bill Marler
Will Kennedy and McAfee team up to start the MASA movement? [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs)   Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]